MedTrace Logo

Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches

NCT06426537 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2024-05-24

No results posted yet for this study

Summary

This study investigates the effect of Colchicine in preventing heart structure changes following ST-segment elevation myocardial infarction. Through a clinical trial involving patients requiring coronary intervention, we explore how Colchicine can reduce inflammation and fibrosis, two crucial factors influencing heart failure post-heart attack. The outcomes are expected to offer new insights into post-heart attack treatments to prevent heart failure.

Conditions

  • ST-Elevation Myocardial Infarction

Interventions

DRUG

Colchicine 0.5 MG Oral Tablet

Oral administration of Colchicine in STEMI patients

Sponsors & Collaborators

  • University of Brawijaya

    lead OTHER

Principal Investigators

  • Tri Astiawati, MD. SpJp · Dr. Iskak General Hospital, Tulungagung, East Java, Indonesia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-20
Primary Completion
2023-03-25
Completion
2023-11-20
FDA Drug
Yes

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06426537 on ClinicalTrials.gov